Advisory Research Inc Shockwave Medical, Inc. Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$223.05 - $302.68 $393,683 - $534,230	-1,765 Reduced 23.21%	5,840 $1.67 Million
Q1 2023 May 12, 2023	BUY	$175.41 - $217.92 $433,087 - $538,044	2,469 Added 48.07%	7,605 $1.65 Million
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $785,329 - $1.25 Million	-4,023 Reduced 43.92%	5,136 $1.43 Million
Q2 2022 Aug 17, 2022	BUY	$115.91 - $214.48 $1.06 Million - $1.96 Million	9,159 New	9,159 $1.75 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.